152 related articles for article (PubMed ID: 34260601)
1. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
[TBL] [Abstract][Full Text] [Related]
2. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Castanon A; Landy R; Sasieni PD
Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
[TBL] [Abstract][Full Text] [Related]
3. Screening and adenocarcinoma of the cervix.
Sasieni P; Castanon A; Cuzick J
Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
[TBL] [Abstract][Full Text] [Related]
4. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
6. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Diagnosis and Treatment of Cervical Adenocarcinoma Compared With Squamous Cell Carcinoma: An Analysis of the National Cancer Database, 2004-2017.
Smith AJB; Beavis AL; Rositch AF; Levinson K
J Low Genit Tract Dis; 2023 Jan; 27(1):29-34. PubMed ID: 36102632
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: a population-based epidemiologic study of 51,842 women in Brazil.
Nogueira-Rodrigues A; Ferreira CG; Bergmann A; de Aguiar SS; Thuler LC
Gynecol Oncol; 2014 Nov; 135(2):292-6. PubMed ID: 25130677
[TBL] [Abstract][Full Text] [Related]
9. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States).
Lacey JV; Frisch M; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Hildesheim A
Cancer Causes Control; 2001 Feb; 12(2):153-61. PubMed ID: 11246844
[TBL] [Abstract][Full Text] [Related]
10. Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods.
Wang M; Huang K; Wong MCS; Huang J; Jin Y; Zheng ZJ
J Epidemiol Glob Health; 2024 Mar; 14(1):94-101. PubMed ID: 38170398
[TBL] [Abstract][Full Text] [Related]
11. Screening frequency and atypical cells and the prediction of cervical cancer risk.
Chen YY; You SL; Koong SL; Liu J; Chen CA; Chen CJ;
Obstet Gynecol; 2014 May; 123(5):1003-1011. PubMed ID: 24785853
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
Wang J; Elfström KM; Andrae B; Nordqvist Kleppe S; Ploner A; Lei J; Dillner J; Sundström K; Sparén P
Int J Cancer; 2020 Mar; 146(5):1230-1240. PubMed ID: 31107987
[TBL] [Abstract][Full Text] [Related]
13. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
Marquardt K; Stubbe M; Broschewitz U
Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
[TBL] [Abstract][Full Text] [Related]
15. Screening history in women with cervical cancer in a Danish population-based screening program.
Kirschner B; Poll S; Rygaard C; Wåhlin A; Junge J
Gynecol Oncol; 2011 Jan; 120(1):68-72. PubMed ID: 21035171
[TBL] [Abstract][Full Text] [Related]
16. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.
Mitchell H; Medley G; Gordon I; Giles G
Br J Cancer; 1995 Apr; 71(4):894-7. PubMed ID: 7710961
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
18. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old.
Chan PG; Sung HY; Sawaya GF
Obstet Gynecol; 2003 Oct; 102(4):765-73. PubMed ID: 14551007
[TBL] [Abstract][Full Text] [Related]
19. Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.
Radde K; Gottschalk A; Bussas U; Schülein S; Schriefer D; Seifert U; Neumann A; Kaiser M; Blettner M; Klug SJ
Int J Cancer; 2016 Sep; 139(5):1018-30. PubMed ID: 27083776
[TBL] [Abstract][Full Text] [Related]
20. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
